139 related articles for article (PubMed ID: 11020004)
1. Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance.
Gutfreund KS; Williams M; George R; Bain VG; Ma MM; Yoshida EM; Villeneuve JP; Fischer KP; Tyrrel DL
J Hepatol; 2000 Sep; 33(3):469-75. PubMed ID: 11020004
[TBL] [Abstract][Full Text] [Related]
2. Genotypic and phenotypic resistance: longitudinal and sequential analysis of hepatitis B virus polymerase mutations in patients with lamivudine resistance after liver transplantation.
Ben-Ari Z; Daudi N; Klein A; Sulkes J; Papo O; Mor E; Samra Z; Gadba R; Shouval D; Tur-Kaspa R
Am J Gastroenterol; 2003 Jan; 98(1):151-9. PubMed ID: 12526951
[TBL] [Abstract][Full Text] [Related]
3. Subclones of drug-resistant hepatitis B virus mutants and the outcome of breakthrough hepatitis in patients treated with lamivudine.
Kumashiro R; Kuwahara R; Ide T; Koga Y; Arinaga T; Hisamochi A; Ogata K; Tanaka K; Sata M
Intervirology; 2003; 46(6):350-4. PubMed ID: 14688451
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.
Yuen MF; Sablon E; Hui CK; Yuan HJ; Decraemer H; Lai CL
Hepatology; 2001 Oct; 34(4 Pt 1):785-91. PubMed ID: 11584376
[TBL] [Abstract][Full Text] [Related]
5. The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance.
Ono SK; Kato N; Shiratori Y; Kato J; Goto T; Schinazi RF; Carrilho FJ; Omata M
J Clin Invest; 2001 Feb; 107(4):449-55. PubMed ID: 11181644
[TBL] [Abstract][Full Text] [Related]
6. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
[TBL] [Abstract][Full Text] [Related]
7. Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.
Nafa S; Ahmed S; Tavan D; Pichoud C; Berby F; Stuyver L; Johnson M; Merle P; Abidi H; Trépo C; Zoulim F
Hepatology; 2000 Nov; 32(5):1078-88. PubMed ID: 11050059
[TBL] [Abstract][Full Text] [Related]
8. Evolution of wild type and mutants of the YMDD motif of hepatitis B virus polymerase during lamivudine therapy.
Zhang X; Liu C; Gong Q; Zhang S; Zhang D; Lu Z; Wang Y
J Gastroenterol Hepatol; 2003 Dec; 18(12):1353-7. PubMed ID: 14675262
[TBL] [Abstract][Full Text] [Related]
9. Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus.
Ono-Nita SK; Kato N; Shiratori Y; Carrilho FJ; Omata M
Antimicrob Agents Chemother; 2002 Aug; 46(8):2602-5. PubMed ID: 12121939
[TBL] [Abstract][Full Text] [Related]
10. Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants.
Jardi R; Buti M; Rodriguez-Frias F; Cotrina M; Costa X; Pascual C; Esteban R; Guardia J
J Virol Methods; 1999 Dec; 83(1-2):181-7. PubMed ID: 10598095
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistance.
Xiong X; Yang H; Westland CE; Zou R; Gibbs CS
Hepatology; 2000 Jan; 31(1):219-24. PubMed ID: 10613749
[TBL] [Abstract][Full Text] [Related]
12. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy.
Stuyver L; Van Geyt C; De Gendt S; Van Reybroeck G; Zoulim F; Leroux-Roels G; Rossau R
J Clin Microbiol; 2000 Feb; 38(2):702-7. PubMed ID: 10655370
[TBL] [Abstract][Full Text] [Related]
13. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy.
Yeh CT; Chien RN; Chu CM; Liaw YF
Hepatology; 2000 Jun; 31(6):1318-26. PubMed ID: 10827158
[TBL] [Abstract][Full Text] [Related]
14. Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy.
Kim KH; Lee KH; Chang HY; Ahn SH; Tong S; Yoon YJ; Seong BL; Kim SI; Han KH
J Med Virol; 2003 Nov; 71(3):367-75. PubMed ID: 12966541
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
[TBL] [Abstract][Full Text] [Related]
16. Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients.
Seta T; Yokosuka O; Imazeki F; Tagawa M; Saisho H
J Med Virol; 2000 Jan; 60(1):8-16. PubMed ID: 10568756
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.
Bartholomew MM; Jansen RW; Jeffers LJ; Reddy KR; Johnson LC; Bunzendahl H; Condreay LD; Tzakis AG; Schiff ER; Brown NA
Lancet; 1997 Jan; 349(9044):20-2. PubMed ID: 8988118
[TBL] [Abstract][Full Text] [Related]
18. HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients.
Fontaine H; Thiers V; Chrétien Y; Zylberberg H; Poupon RE; Bréchot C; Legendre C; Kreis H; Pol S
Transplantation; 2000 May; 69(10):2090-4. PubMed ID: 10852602
[TBL] [Abstract][Full Text] [Related]
19. Detection of hepatitis B virus resistance to antivirals.
Zoulim F
J Clin Virol; 2001 Jun; 21(3):243-53. PubMed ID: 11397661
[TBL] [Abstract][Full Text] [Related]
20. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy.
Chayama K; Suzuki Y; Kobayashi M; Kobayashi M; Tsubota A; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Murashima N; Ikeda K; Kumada H
Hepatology; 1998 Jun; 27(6):1711-6. PubMed ID: 9620347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
